Local view for "http://purl.org/linkedpolitics/eu/plenary/2001-05-02-Speech-3-200"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20010502.15.3-200"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spoken text |
"On behalf of the Commission, I would like to thank Mrs Doyle and the Committee on the Environment, Public Health and Consumer Policy for this report.
There are many different perspectives to be reconciled. Unfortunately, no satisfactory solution has yet been found. The communication aimed to present the Commission's view on the problem of veterinary medicine availability and noted with satisfaction that the committee and the rapporteur share the general concerns of the Commission on this issue. This communication clearly does not bring a direct solution; however, it outlines the options for further action in both the long and short term.
It is important to point out that the current veterinary and pharmaceutical legislation provides a framework designed to ensure, amongst other things, the optimal protection of consumer health. This legislation is currently being reviewed. This review will provide a timed framework to further address the availability problem for all animal species concerned in a global manner. Any proposal for change to ease the access to the market of veterinary and pharmaceutical products, or to facilitate the use of certain medicines by veterinarians, will be in the interest of animal health and welfare. However, it goes without saying that any of these proposals will have to be compatible with the objective of consumer health protection. With this end in mind, I am cooperating with colleagues, Mr Byrne, in particular, and I expect the legislative proposal to be finalised within a few months. This will allow an in-depth discussion with the European Parliament and the Council on all relevant matters. Obviously, these legislative changes will take some time.
The Commission has therefore also announced its approval of the principle of extrapolating maximum residue limits established for some species to other species. Such an exploration would only be possible under certain conditions. While we recognise that extrapolating maximum residue limits cannot be a global solution, we believe that it can represent a practical improvement of the situation, particularly in the short term. However, it also raises the complex technical issues, in particular the link with the possible illegal use of certain substances. Thus, a need for appropriate analytical methods of control will have to be considered. I am hoping that the further work in close cooperation between the European Parliament, the Council and the Commission will lead to a balanced solution, offering a framework for genuine benefit to animal health, while maintaining a high level of consumer protection."@en1
|
| lpv:unclassifiedMetadata |
Named graphs describing this resource:
The resource appears as object in 2 triples